Norris M, Bluhm A, Metrailer M, Jiranantasak T, Kirpich A, Hadfield T
Sci Rep. 2023; 13(1):5060.
PMID: 36977718
PMC: 10050317.
DOI: 10.1038/s41598-023-32162-x.
Alam M, Kamal M, Rahman M, Kabir A, Islam M, Hassan J
J Adv Vet Anim Res. 2022; 9(2):323-334.
PMID: 35891653
PMC: 9298093.
DOI: 10.5455/javar.2022.i599.
Lee V
Annu Rep Med Chem. 2020; 39:211-221.
PMID: 32287465
PMC: 7127116.
DOI: 10.1016/S0065-7743(04)39017-2.
Momben Abolfath S, Kolberg M, Karginov V, Leppla S, Nestorovich E
Biophys J. 2019; 117(9):1751-1763.
PMID: 31587826
PMC: 6838753.
DOI: 10.1016/j.bpj.2019.08.041.
Li L, Guo Q, Liu J, Zhang J, Yin Y, Dong D
Toxins (Basel). 2016; 8(1).
PMID: 26805881
PMC: 4728550.
DOI: 10.3390/toxins8010028.
Designing inhibitors of anthrax toxin.
Nestorovich E, Bezrukov S
Expert Opin Drug Discov. 2014; 9(3):299-318.
PMID: 24447197
PMC: 4307821.
DOI: 10.1517/17460441.2014.877884.
Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users.
Russell L, Pedersen M, Jensen A, Soes L, Hansen A
BMC Infect Dis. 2013; 13:408.
PMID: 24004900
PMC: 3844346.
DOI: 10.1186/1471-2334-13-408.
An overview of anthrax infection including the recently identified form of disease in injection drug users.
Hicks C, Sweeney D, Cui X, Li Y, Eichacker P
Intensive Care Med. 2012; 38(7):1092-104.
PMID: 22527064
PMC: 3523299.
DOI: 10.1007/s00134-012-2541-0.
Anthrax infection.
Sweeney D, Hicks C, Cui X, Li Y, Eichacker P
Am J Respir Crit Care Med. 2011; 184(12):1333-41.
PMID: 21852539
PMC: 3361358.
DOI: 10.1164/rccm.201102-0209CI.
Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination.
Cao S, Guo A, Liu Z, Tan Y, Wu G, Zhang C
Infect Immun. 2009; 77(10):4679-87.
PMID: 19620345
PMC: 2747968.
DOI: 10.1128/IAI.00264-09.
SAR studies for a new class of antibacterial NAD biosynthesis inhibitors.
Moro W, Yang Z, Kane T, Zhou Q, Harville S, Brouillette C
J Comb Chem. 2009; 11(4):617-25.
PMID: 19408950
PMC: 2888690.
DOI: 10.1021/cc9000357.
X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.
Bennett B, Wan Q, Ahmad M, Langan P, Dealwis C
J Struct Biol. 2009; 166(2):162-71.
PMID: 19374017
PMC: 2738603.
DOI: 10.1016/j.jsb.2009.01.001.
Risk factors associated with anthrax outbreak in animals in North Dakota, 2005: a retrospective case-control study.
Mongoh M, Dyer N, Stoltenow C, Khaitsa M
Public Health Rep. 2008; 123(3):352-9.
PMID: 19006977
PMC: 2289988.
DOI: 10.1177/003335490812300315.
Bacillus anthracis secretes proteins that mediate heme acquisition from hemoglobin.
Maresso A, Garufi G, Schneewind O
PLoS Pathog. 2008; 4(8):e1000132.
PMID: 18725935
PMC: 2515342.
DOI: 10.1371/journal.ppat.1000132.
Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cells.
Das R, Hammamieh R, Neill R, Ludwig G, Eker S, Lincoln P
BMC Infect Dis. 2008; 8:104.
PMID: 18667072
PMC: 2542375.
DOI: 10.1186/1471-2334-8-104.
Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.
Karginov V, Nestorovich E, Yohannes A, Robinson T, Fahmi N, Schmidtmann F
Antimicrob Agents Chemother. 2006; 50(11):3740-53.
PMID: 16982795
PMC: 1635233.
DOI: 10.1128/AAC.00693-06.
Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
Karginov V, Nestorovich E, Moayeri M, Leppla S, Bezrukov S
Proc Natl Acad Sci U S A. 2005; 102(42):15075-80.
PMID: 16214885
PMC: 1257733.
DOI: 10.1073/pnas.0507488102.
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.
Opal S, Artenstein A, Cristofaro P, Jhung J, Palardy J, Parejo N
Infect Immun. 2005; 73(8):5101-5.
PMID: 16041026
PMC: 1201260.
DOI: 10.1128/IAI.73.8.5101-5105.2005.
Effective antiprotease-antibiotic treatment of experimental anthrax.
Popov S, Popova T, Hopkins S, Weinstein R, MacAfee R, Fryxell K
BMC Infect Dis. 2005; 5:25.
PMID: 15819985
PMC: 1090577.
DOI: 10.1186/1471-2334-5-25.
Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
Bardwell A, Abdollahi M, Bardwell L
Biochem J. 2003; 378(Pt 2):569-77.
PMID: 14616089
PMC: 1223970.
DOI: 10.1042/BJ20031382.
